111 related articles for article (PubMed ID: 9054464)
1. Cortisol and estradiol: nongenetic factors for hyperhomocyst(e)inemia.
Kim MH; Kim E; Passen EL; Meyer J; Kang SS
Metabolism; 1997 Mar; 46(3):247-9. PubMed ID: 9054464
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocyst(e)inemia, anti-estrogen antibodies and other risk factors for thrombosis in women on oral contraceptives.
Beaumont V; Malinow MR; Sexton G; Wilson D; Lemort N; Upson B; Beaumont JL
Atherosclerosis; 1992 Jun; 94(2-3):147-52. PubMed ID: 1632868
[TBL] [Abstract][Full Text] [Related]
3. Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine.
Ducloux D; Fournier V; Rebibou JM; Bresson-Vautrin C; Gibey R; Chalopin JM
Clin Nephrol; 1998 Apr; 49(4):232-5. PubMed ID: 9582553
[TBL] [Abstract][Full Text] [Related]
4. Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia.
Kang SS; Wong PW
Atherosclerosis; 1996 Jan; 119(2):135-8. PubMed ID: 8808490
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
Manns BJ; Burgess ED; Hyndman ME; Parsons HG; Schaefer JP; Scott-Douglas NW
Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study.
Langman LJ; Ray JG; Evrovski J; Yeo E; Cole DE
Arch Intern Med; 2000 Apr; 160(7):961-4. PubMed ID: 10761961
[TBL] [Abstract][Full Text] [Related]
7. Hyperhomocyst(e)inemia induces multiorgan damage.
Miller A; Mujumdar V; Shek E; Guillot J; Angelo M; Palmer L; Tyagi SC
Heart Vessels; 2000; 15(3):135-43. PubMed ID: 11289502
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.
Coull BM; Malinow MR; Beamer N; Sexton G; Nordt F; de Garmo P
Stroke; 1990 Apr; 21(4):572-6. PubMed ID: 2326839
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
Hofmann MA; Kohl B; Zumbach MS; Borcea V; Bierhaus A; Henkels M; Amiral J; Schmidt AM; Fiehn W; Ziegler R; Wahl P; Nawroth PP
Diabetes Care; 1998 May; 21(5):841-8. PubMed ID: 9589252
[TBL] [Abstract][Full Text] [Related]
10. Causes and consequences of hyperhomocyst(e)inemia.
Pietrzik K; Brönstrup A
Int J Vitam Nutr Res; 1997; 67(5):389-95. PubMed ID: 9350483
[TBL] [Abstract][Full Text] [Related]
11. Determinants of plasma homocyst(e)ine in patients with nephrotic syndrome.
Joven J; Arcelús R; Camps J; Ordóñez-Llanos J; Vilella E; González-Sastre F; Blanco-Vaca F
J Mol Med (Berl); 2000; 78(3):147-54. PubMed ID: 10868477
[TBL] [Abstract][Full Text] [Related]
12. Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis.
Lee YK; Kwon YJ; Yoon JW; Oh KS; Cha DR; Cho WY; Huh K; Pyo HJ; Kim HK
J Korean Med Sci; 1999 Apr; 14(2):193-8. PubMed ID: 10331567
[TBL] [Abstract][Full Text] [Related]
13. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
Hofmann MA; Kohl B; Zumbach MS; Borcea V; Bierhaus A; Henkels M; Amiral J; Fiehn W; Ziegler R; Wahl P; Nawroth PP
Diabetes Care; 1997 Dec; 20(12):1880-6. PubMed ID: 9405911
[TBL] [Abstract][Full Text] [Related]
14. Total homocyst(e)ine in plasma and amniotic fluid of pregnant women.
Kang SS; Wong PW; Zhou JM; Cook HY
Metabolism; 1986 Oct; 35(10):889-91. PubMed ID: 3762398
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Semmelrock J; Haas A
Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
[TBL] [Abstract][Full Text] [Related]
16. Plasma homocyst(e)ine concentrations in pregnant and nonpregnant women with controlled folate intake.
Bonnette RE; Caudill MA; Boddie AM; Hutson AD; Kauwell GP; Bailey LB
Obstet Gynecol; 1998 Aug; 92(2):167-70. PubMed ID: 9699744
[TBL] [Abstract][Full Text] [Related]
17. Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men.
von Eckardstein A; Malinow MR; Upson B; Heinrich J; Schulte H; Schönfeld R; Köhler E; Assmann G
Arterioscler Thromb; 1994 Mar; 14(3):460-4. PubMed ID: 8123652
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocyst(e)inemia and Chlamydia pneumoniae IgG seropositivity in patients with coronary artery disease.
Stanger OH; Semmelrock HJ; Rehak P; Tiran B; Meinitzer A; Rigler B; Tiran A
Atherosclerosis; 2002 May; 162(1):157-62. PubMed ID: 11947909
[TBL] [Abstract][Full Text] [Related]
19. Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background.
Moghadasian MH; McManus BM; Frohlich JJ
Arch Intern Med; 1997 Nov; 157(20):2299-308. PubMed ID: 9361570
[TBL] [Abstract][Full Text] [Related]
20. Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial.
Sesmilo G; Biller BM; Llevadot J; Hayden D; Hanson G; Rifai N; Klibanski A
J Clin Endocrinol Metab; 2001 Apr; 86(4):1518-24. PubMed ID: 11297577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
